Polish University to Use Cellectricon HT System | GenomeWeb

NEW YORK (GenomeWeb News) – Poland's University of Lodz will use Cellectricon's cell-based screening system in its genomic research programs, the company said today.

Under the agreement, the university will use the Cellaxess HT system for high-throughput transfection, which the company said enables the delivery of any genetic material to cells without the use of reagents.

The university bought the Cellaxess system with funding from Poland's Innovative Economy Operational Program, which is supported in part by the EU's European Regional Development Fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.